MYD88 and CD79B mutation-induced constitutive NF-kB activation, Prdm1 inactivation-caused blockade of PC differentiation, and BCL2 overexpression mediated inhibition of apoptosis collectively drive aberrant spontaneous expansion of splenic GCBs and ultimately result in the development of MCD-DLBCL in a mouse model.